Insights from diversified anti-angiogenic models: Role of β-interferon inducer DEAE-Dextran

Substantially, DEAE-Dextran leads to anti-tumor activity through anti-angiogenic action and a combination of in vitro and in vivo model is vital for the judgement of anti-angiogenic potential since an in vitro model exempts mammalian-culture considerations.